MolNFT glossary and cross database search

NFTID Title Collection Structure title FASTA sequences
1734 P50407 AF NFT 5-hydroxytryptamine receptor 7 >sp|P50407|5HT7R_CAVPO 5-hydroxytryptamine receptor 7 OS=Cavia porcellus OX=10141 GN=HTR7 PE=2 SV=1 MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
1734 HLA01831 C*04:04:02 HLA NFT C*04:04:02 >HLA:HLA01831 C*04:04:02 366 bp MRVMAPRTLILLLSGALALTETWAGSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWKPSSQPTIPIVGIVAGLAVLAVLAVLGAMVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1735 HLA01832 C*05:07N HLA NFT C*05:07N >HLA:HLA01832 C*05:07N 137 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHPPEDVWLRPGARRAPPPRVX
1735 P34969 AF NFT 5-hydroxytryptamine receptor 7 >sp|P34969|5HT7R_HUMAN 5-hydroxytryptamine receptor 7 OS=Homo sapiens OX=9606 GN=HTR7 PE=1 SV=2 MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD
1735 1BAP PDB NFT A PRO TO GLY MUTATION IN THE HINGE OF THE ARABINOSE-BINDING PROTEIN ENHANCES BINDING AND ALTERS SPECIFICITY: SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES >1bap_A mol:protein length:306 L-ARABINOSE-BINDING PROTEIN ENLKLGFLVKQPEEPWFQTEWKFADKAGKDLGFEVIKIAVPDGEKTLNAIDSLAASGAKGFVICTPDPKLGSAIVAKARGYDMKVIAVDDQFVNAKGKPMDTVPLVMMAATKIGERQGQELYKEMQKRGWDVKESAVMAITANELDTARRRTTGSMDALKAAGFPEKQIYQVPTKSNDIPGAFDAANSMLVQHPEVKHWLIVGMNDSTVLGGVRATEGQGFKAADIIGIGINGVDAVSELSKAQATGFYGSLLGSPDVHGYKSSEMLYNWVAKDVEPPKFTEVTDVVLITRDNFKEELEKKGLGGK
1736 1BAR PDB NFT THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS >1bar_A mol:protein length:140 ACIDIC FIBROBLAST GROWTH FACTOR FNLPLGNYKKPKLLYCSNGGYFLRILPDGTVDGTKDRSDQHIQLQLAAESIGEVYIKSTETGQFLAMDTDGLLYGSQTPNEECLFLERLEENGYNTYISKKHAEKHWFVGLKKNGRSKLGPRTHFGQKAILFLPLPVSSD >1bar_B mol:protein length:140 ACIDIC FIBROBLAST GROWTH FACTOR FNLPLGNYKKPKLLYCSNGGYFLRILPDGTVDGTKDRSDQHIQLQLAAESIGEVYIKSTETGQFLAMDTDGLLYGSQTPNEECLFLERLEENGYNTYISKKHAEKHWFVGLKKNGRSKLGPRTHFGQKAILFLPLPVSSD
1736 P32304 AF NFT 5-hydroxytryptamine receptor 7 >sp|P32304|5HT7R_MOUSE 5-hydroxytryptamine receptor 7 OS=Mus musculus OX=10090 GN=Htr7 PE=2 SV=2 MMDVNSSGRPDLYGHLRSLILPEVGRRLQDLSPDGGAHSVVSSWMPHLLSGFPEVTASPAPTWDAPPDNVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFSGFPRVQPESVISLNGVVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERSEFVLQNCDHCGKKGHDT
1736 HLA01833 C*07:21 HLA NFT C*07:21 >HLA:HLA01833 C*07:21 366 bp MRVMAPRALLLLLSGGLALTETWACSHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASSRGEPRAPWVEQEGPEYWDRETQNYKRQAQADRVSLRNLRGYYNQSEDGSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKLEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRAEPPKTHVTHHPLSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHMQHEGLQEPLTLSWEPSSQPTIPIMGIVAGLAVLVVLAVLGAVVTAMMCRRKSSGGKGGSCSQAACSNSAQGSDESLITCKA
1737 HLA01834 A*23:11N HLA NFT A*23:11N >HLA:HLA01834 A*23:11N 84 bp MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGSPASSPWATWTTRSSCGSTATPRARGWSRGRRGX
1737 P32305 AF NFT 5-hydroxytryptamine receptor 7 >sp|P32305|5HT7R_RAT 5-hydroxytryptamine receptor 7 OS=Rattus norvegicus OX=10116 GN=Htr7 PE=2 SV=2 MMDVNSSGRPDLYGHLRSLILPEVGRGLQDLSPDGGAHPVVSSWMPHLLSGFLEVTASPAPTWDAPPDNVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVQPESVISLNGVVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERSEFVLQNSDHCGKKGHDT
1737 1BAS PDB NFT THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS >1bas_A mol:protein length:154 BASIC FIBROBLAST GROWTH FACTOR AAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS
1738 1BAU PDB NFT NMR STRUCTURE OF THE DIMER INITIATION COMPLEX OF HIV-1 GENOMIC RNA, MINIMIZED AVERAGE STRUCTURE >1bau_A mol:na length:23 SL1 RNA DIMER GGCAAUGAAGCGCGCACGUUGCC >1bau_B mol:na length:23 SL1 RNA DIMER GGCAAUGAAGCGCGCACGUUGCC
1738 Q91559 AF NFT 5-hydroxytryptamine receptor 7 >sp|Q91559|5HT7R_XENLA 5-hydroxytryptamine receptor 7 OS=Xenopus laevis OX=8355 GN=htr7 PE=2 SV=1 MLIQVQPSHLTDTNLSLHSAKPSSDHQNLLPSEFMTERPLNTTEQDLTALNHTEKPDCGKELLLYGDTEKIVIGVVLSIITLFTIAGNALVIISVCIVKKLRQPSNYLVVSLAAADLSVAVAVMPFVIITDLVGGEWLFGKVFCNVFIAMDVMCCTASIMTLCVISVDRYLGITRPLTYPARQNGKLMAKMVFIVWLLSASITLPPLFGWAKNVNVERVCLISQDFGYTVYSTAVAFYIPMTVMLVMYQRIFVAAKISAEKHKFVNIPRLYEQEGIYCLEDKLPPKKNSKKKKAVEEFASLSKLIRQDRKNISIFKREQKAARTLGIIVGAFTFCWLPFFLLSTARPFICGIMCSCMPLRLERTLLWLGYTNSLINPLIYAFFNRDLRTTFWNLLRCKYTNINRRLSAASMHEALKVTERHEGIL
1738 HLA01835 C*08:10 HLA NFT C*08:10 >HLA:HLA01835 C*08:10 366 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARTAEQLRAYLEGTCVEWLRRYLENGKKTLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWGPSSQPTIPIVGIVAGLAVLAVLAVLGAVMAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1739 HLA01836 DRB1*08:27 HLA NFT DRB1*08:27 >HLA:HLA01836 DRB1*08:27 89 bp RFLEYSTGECYFFNGTERVRFLDRYFYNREEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDILEDRRALVDTYCRHNYGVGESFTVQRR
1739 Q16950 AF NFT 5-hydroxytryptamine receptor 1 >sp|Q16950|5HTB1_APLCA 5-hydroxytryptamine receptor 1 OS=Aplysia californica OX=6500 GN=5HTB1 PE=2 SV=1 MKSLKSSTHDVPHPEHVVWAPPAYDEQHHLFFSHGTVLIGIVGSLIITVAVVGNVLVCLAIFTEPILSHSKSNFFIVSLAVADLLLALLVMTFALVNDMYGYWLFGETFCFIWMSADVMCETASIFSICVISYDRLKQVQKPLHYEEFMTTTRALLIIACLWICSFVLSFVPIFLEWHELSVEEIKAIFKDNKTEKEKALEAHNFSSALNQTLGDNQKSNAKHVCLFDVHFTYSVIYSFICFYVPCTLMLTNYLRLFLIAQTHQVRIRSLQMTNPPQLRGQGASSYRNQGTQGSKAARTLTIITGTFLACWLPFFIINPIAAADEHLIPLECFMVTIWLGYFNSSVNPIIYGTSNSKFRAAFKRLLRCRSVKSVVGSISPVSPAYRAFSWIRPSRLDLSSSEHPSDACDTGRGKNSKGGDCATADPTKPDVSVSEEIIYAGTKVFDSDTAFSS
1739 1BAV PDB NFT CARBOXYPEPTIDASE A COMPLEXED WITH 2-BENZYL-3-IODO-PROPANOIC ACID (BIP) >1bav_A mol:protein length:309 CARBOXYPEPTIDASE A ARSTNTFNYATYHTLDEIYDFMDLLVAQHPELVSKLQIGRSYEGRPIYVLKFSTGGSNRPAIWIDLGIHSREWITQATGVWFAKKFTENYGQNPSFTAILDSMDIFLEIVTNPNGFAFTHSENRLWRKTRSVTSSSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIVDFVKNHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVAALKSLYGTSYKYGSIITTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTIMEHTVNNLY >1bav_B mol:protein length:309 CARBOXYPEPTIDASE A ARSTNTFNYATYHTLDEIYDFMDLLVAQHPELVSKLQIGRSYEGRPIYVLKFSTGGSNRPAIWIDLGIHSREWITQATGVWFAKKFTENYGQNPSFTAILDSMDIFLEIVTNPNGFAFTHSENRLWRKTRSVTSSSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIVDFVKNHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVAALKSLYGTSYKYGSIITTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTIMEHTVNNLY >1bav_C mol:protein length:309 CARBOXYPEPTIDASE A ARSTNTFNYATYHTLDEIYDFMDLLVAQHPELVSKLQIGRSYEGRPIYVLKFSTGGSNRPAIWIDLGIHSREWITQATGVWFAKKFTENYGQNPSFTAILDSMDIFLEIVTNPNGFAFTHSENRLWRKTRSVTSSSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIVDFVKNHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVAALKSLYGTSYKYGSIITTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTIMEHTVNNLY >1bav_D mol:protein length:309 CARBOXYPEPTIDASE A ARSTNTFNYATYHTLDEIYDFMDLLVAQHPELVSKLQIGRSYEGRPIYVLKFSTGGSNRPAIWIDLGIHSREWITQATGVWFAKKFTENYGQNPSFTAILDSMDIFLEIVTNPNGFAFTHSENRLWRKTRSVTSSSLCVGVDANRNWDAGFGKAGASSSPCSETYHGKYANSEVEVKSIVDFVKNHGNFKAFLSIHSYSQLLLYPYGYTTQSIPDKTELNQVAKSAVAALKSLYGTSYKYGSIITTIYQASGGSIDWSYNQGIKYSFTFELRDTGRYGFLLPASQIIPTAQETWLGVLTIMEHTVNNLY
1740 1BAW PDB NFT PLASTOCYANIN FROM PHORMIDIUM LAMINOSUM >1baw_A mol:protein length:105 PLASTOCYANIN ETFTVKMGADSGLLQFEPANVTVHPGDTVKWVNNKLPPHNILFDDKQVPGASKELADKLSHSQLMFSPGESYEITFSSDFPAGTYTYYCAPHRGAGMVGKITVEG >1baw_B mol:protein length:105 PLASTOCYANIN ETFTVKMGADSGLLQFEPANVTVHPGDTVKWVNNKLPPHNILFDDKQVPGASKELADKLSHSQLMFSPGESYEITFSSDFPAGTYTYYCAPHRGAGMVGKITVEG >1baw_C mol:protein length:105 PLASTOCYANIN ETFTVKMGADSGLLQFEPANVTVHPGDTVKWVNNKLPPHNILFDDKQVPGASKELADKLSHSQLMFSPGESYEITFSSDFPAGTYTYYCAPHRGAGMVGKITVEG
1740 Q16951 AF NFT 5-hydroxytryptamine receptor 2 >sp|Q16951|5HTB2_APLCA 5-hydroxytryptamine receptor 2 OS=Aplysia californica OX=6500 GN=5HTB2 PE=2 SV=1 MLCGRLRHTMNSTTCFFSHRTVLIGIVGSLIIAVSVVGNVLVCLAIFTEPILSHSKSKFFIVSLAVADLLLALLVMTFALVNSLYGYWLFGETFCFIWMSADVMCETASIFSICVISYNRLKQVQKPLQYEEFMTTTRALLIIASLWICSFVVSFVPFFLEWHELSMEEIKTIFKDLISDKVKTSDAHTFSFALEQTLGDNRTSNPKPECLFDVHFIYSVIYSLFCFYIPCTLMLRNYLRLFLIAKKHHVRIKNLHRLHRNQGTQGSKAARTLTIITGTFLACWLPFFIINPIEAVDEHLIPLECFMVTIWLGYFNSCVNPIIYGTSNSKFRAAFQRLLRCRSVKSTVSSISPVASVYRAFSWIRPSLLDGPPSAVCDTGQDENRKGGGCVTTIPTESHVIISEEEIRANVMLSESDTVFS
1740 HLA01837 DPB1*100:01 HLA NFT DPB1*100:01 >HLA:HLA01837 DPB1*100:01 181 bp NYLFQGRQECYAFNGTQRFLERYIYNREELVRFDSDVGEFRAVTELGRPEAEYWNSQKDILEEKRAVPDRMCRHNYELGGPMTLQRRVQPRVNVSPSKKGPLQHHNLLVCHVTDFYPGSIQVRWFLNGQEETAGVVSTNLIRNGDWTFQILVMLEMTPQQGDVYTCQVEHTSLDSPVTVEW
1741 HLA01838 DRB1*16:05:02 HLA NFT DRB1*16:05:02 >HLA:HLA01838 DRB1*16:05:02 89 bp RFLWQPKRECHFFNGTERVRFLDRYFYNQEESVRFDSDVGEYRAVTELGRPDAEYWNSQKDILEDRRAAVDTYCRHNYGVGESFTVQRR
1741 Q17239 AF NFT 5-hydroxytryptamine receptor >sp|Q17239|5HTR_BOMMO 5-hydroxytryptamine receptor OS=Bombyx mori OX=7091 PE=2 SV=1 MEGAEGQEELDWEALYLRLPLQNCSWNSTGWEPNWNVTVVPNTTWWQASAPFDTPAALVRAAAKAVVLGLLILATVVGNVFVIAAILLERHLRSAANNLILSLAVADLLVACLVMPLGAVYEVVQRWTLGPELCDMWTSGDVLCCTASILHLVAIALDRYWAVTNIDYIHASTAKRVGMMIACVWTVSFFVCIAQLLGWKDPDWNQRVSEDLRCVVSQDVGYQIFATASSFYVPVLIILILYWRIYQTARKRIRRRRGATARGGVGPPPVPAGGALVAGGGSGGIAAAVVAVIGRPLPTISETTTTGFTNVSSNNTSPEKQSCANGLEADPPTTGYGAVAAAYYPSLVRRKPKEAADSKRERKAAKTLAIITGAFVACWLPFFVLAILVPTCDCEVSPVLTSLSLWLGYFNSTLNPVIYTVFSPEFRHAFQRLLCGRRVRRRRAPQ
1741 1BAX PDB NFT MASON-PFIZER MONKEY VIRUS MATRIX PROTEIN, NMR, AVERAGE STRUCTURE >1bax_A mol:protein length:94 M-PMV MATRIX PROTEIN MGQELSQHERYVEQLKQALKTRGVKVKYADLLKFFDFVKDTCPWFPQEGTIDIKRWRRVGDCFQDYYNTFGPEKVPVTAFSYWNLIKELIDKKE
1742 1BAY PDB NFT GLUTATHIONE S-TRANSFERASE YFYF CYS 47-CARBOXYMETHYLATED CLASS PI, FREE ENZYME >1bay_A mol:protein length:209 GLUTATHIONE S-TRANSFERASE CLASS PI PPYTIVYFPVRGRCEAMRMLLADQGQSWKEEVVTIDTWMQGLLKPTCLYGQLPKFEDGDLTLYQSNAILRHLGRSLGLYGKNQREAAQMDMVNDGVEDLRGKYVTLIYTNYENGKNDYVKALPGHLKPFETLLSQNQGGKAFIVGDQISFADYNLLDLLLIHQVLAPGCLDNFPLLSAYVARLSARPKIKAFLSSPEHVNRPINGNGKQ >1bay_B mol:protein length:209 GLUTATHIONE S-TRANSFERASE CLASS PI PPYTIVYFPVRGRCEAMRMLLADQGQSWKEEVVTIDTWMQGLLKPTCLYGQLPKFEDGDLTLYQSNAILRHLGRSLGLYGKNQREAAQMDMVNDGVEDLRGKYVTLIYTNYENGKNDYVKALPGHLKPFETLLSQNQGGKAFIVGDQISFADYNLLDLLLIHQVLAPGCLDNFPLLSAYVARLSARPKIKAFLSSPEHVNRPINGNGKQ
1742 Q25190 AF NFT 5-hydroxytryptamine receptor >sp|Q25190|5HTR_HELVI 5-hydroxytryptamine receptor OS=Heliothis virescens OX=7102 PE=2 SV=1 MNASRLPGFNDTSQDQPYPTSSEWFDGSNCSWVDAVSWGCNVTINGTSTNATSTDVTSFVLMAVTSVVLALIILATIVGNVFVIAAIIIERNLQNVANYLVASLAVADLMVACLVMPLGAVYEVSQGWILGPELCDMWTSSDVLCSSASILHLVAIATDRYWAVTDVDYIHIRNEKRIFTMIVLVWGAALVVSLAPQLGWKDPDYLARITQQQKCLVSQDLAYQIFATMSTFYVPLAVILILYWKIFQTARRRIRRRRDPPPPRPTSADGATPSGRPVQSARDRRFVKKRFLNLKKCNQRTRAETLAAALLLTEGQSTSTVDTLDEEPRTTAFTINEKVPPSVSPEKSSSTVTNGSKPERAIVPAPTHREKKESLEAKRERKAAKTLAIITGAFVFCWLPFFIMALVMPICQTCVISDYLASFFLWLGYFNSTLNPVIYTIFSPDFRQAFARILFGTHRRRRYKKF
1742 HLA01839 A*11:17 HLA NFT A*11:17 >HLA:HLA01839 A*11:17 181 bp SHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNMKAHSQTDRANLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQQRAYLEGRCVEWLRRYLENGKETLQRT
1743 HLA01840 B*13:12:01 HLA NFT B*13:12:01 >HLA:HLA01840 B*13:12:01 362 bp MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFITVGYVDDTQFVRFDSDATSPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHNQLAYDGKDYIALNEDLSSWTAADTAAQITQLKWEAARVAEQLRAYLEGGCVEWLRRYLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACSDSAQGSDVSLTA
1743 Q25414 AF NFT 5-hydroxytryptamine receptor >sp|Q25414|5HTR_LYMST 5-hydroxytryptamine receptor OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 MANFTFGDLALDVARMGGLASTPSGLRSTGLTTPGLSPTGLVTSDFNDSYGLTGQFINGSHSSRSRDNASANDTSATNMTDDRYWSLTVYSHEHLVLTSVILGLFVLCCIIGNCFVIAAVMLERSLHNVANYLILSLAVADLMVAVLVMPLSVVSEISKVWFLHSEVCDMWISVDVLCCTASILHLVAIAMDRYWAVTSIDYIRRRSARRILLMIMVVWIVALFISIPPLFGWRDPNNDPDKTGTCIISQDKGYTIFSTVGAFYLPMLVMMIIYIRIWLVARSRIRKDKFQMTKARLKTEETTLVASPKTEYSVVSDCNGCNSPDSTTEKKKRRAPFKSYGCSPRPERKKNRAKKLPENANGVNSNSSSSERLKQIQIETAEAFANGCAEEASIAMLERQCNNGKKISSNDTPYSRTREKLELKRERKAARTLAIITGAFLICWLPFFIIALIGPFVDPEGIPPFARSFVLWLGYFNSLLNPIIYTIFSPEFRSAFQKILFGKYRRGHR
1743 1BAZ PDB NFT ARC REPRESSOR MUTANT PHE10VAL >1baz_A mol:protein length:53 ARC REPRESSOR MKGMSKMPQVNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA >1baz_B mol:protein length:53 ARC REPRESSOR MKGMSKMPQVNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA >1baz_C mol:protein length:53 ARC REPRESSOR MKGMSKMPQVNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA >1baz_D mol:protein length:53 ARC REPRESSOR MKGMSKMPQVNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA
1744 1BB0 PDB NFT THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES >1bb0_A mol:protein length:36 THROMBIN TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR >1bb0_B mol:protein length:259 THROMBIN IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE >1bb0_C mol:protein length:13 HIRUGEN XDGDFEEIPEEYL
1744 Q8W1W9 AF NFT Malonyl-coenzyme:anthocyanin 5-O-glucoside-6'''-O-malonyltransferase >sp|Q8W1W9|5MAT1_SALSN Malonyl-coenzyme:anthocyanin 5-O-glucoside-6'''-O-malonyltransferase OS=Salvia splendens OX=180675 GN=5MAT1 PE=1 SV=1 MTTTTTILETCHIPPPPAANDLSIPLSFFDIKWLHYHPVRRLLFYHHPSSKSQFLHTIVPHLKQSLSLALTHYLPVAGNLLYPSNTEKFPQLRYAAGDSVPVTIAESNSDFESLTGNHTRDADQFYDLLPPIPPIEEESDWKLINIFAVQITLFPGEGICIGFSNHHCLGDARSIVGFISAWGEINGIGGYEGFLSNHSDSLSLPIFDRSFINDPNKIDAIFWKVLRNIPLKTASFPLPTNRVRSTFLLRRSDIEKLKTATKSPASSFVAAAAFVWSCMVKSGDKSDENAPELFIIPADARGRVDPPIPENYFGNCIVSSVAQVERGKLAAEDGFAVAAEAIGGEIEGKLKNRDEILRGAENWMSDIFKCFGMSVLGVSGSPKFDLLKADFGWGKARKLEVLSIDGENHSMSLCSSSDFNGGLEVGLSLPRERMAAFEEVFRASIMAASGPARRSPALVEPL
1744 HLA01841 DRB1*11:48 HLA NFT DRB1*11:48 >HLA:HLA01841 DRB1*11:48 183 bp RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEYRAVTELGRPDEEYWNSQKDILEDERAAVDTYCRHNYGVVESFTVQRRVHPKVTVYPSKTQPLQHHNLLVCSVSGFYPGSIEVRWFRNGQEEKTGVVSTGLIHNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEW
1745 HLA01842 DRB1*15:14 HLA NFT DRB1*15:14 >HLA:HLA01842 DRB1*15:14 89 bp RFLWQPKRECHFFNATERVRFLDRYFYNQEESVRFDSDVGEFRAVTELGRPDAEYWNSQKDILEQARAAVDTYCRHNYGVGESFTVQRR
1745 Q6TXD2 AF NFT Pelargonidin 3-O-(6-caffeoylglucoside) 5-O-(6-O-malonylglucoside) 4'''-malonyltransferase >sp|Q6TXD2|5MAT2_SALSN Pelargonidin 3-O-(6-caffeoylglucoside) 5-O-(6-O-malonylglucoside) 4'''-malonyltransferase OS=Salvia splendens OX=180675 PE=1 SV=1 MNINQINTKLIKPITPTPQNLKNYHISFLDQHVVKKYIAVVLYYQSAPDNGRLEDSLAETLVHFYPLAGRYIKTDLTVDCSDQGAEFIEAEARGDVRVTDLIGKTDTIHLCPEQYFGLDEGVDDPLLSIQVTRFSCGGATIAVSVSHRVFDVSSLETFLSAWSSASKTGGGVAPVIPSFALASLLPNKDEKFGLDSNKCQGKEQKIAVKRLLFEKRALTRLTSERTSGVRAACAVIAKALIRLDRTTHGKSRDFVVFQPINMRGRTGVPSPKNACGNMSFGSFTRRVSAKEEVGIGELVGLIGDGVRRGIAEYTEILCPDRDGRDVIIHVRNKNIKEVFKSETFVVSFTDWSKFGFYEVDFGWGRPIWSGVGPQRPRGNQTIMMRSKEGDGIEAWVHLNEDDMDLFEQDVEIKLFLS
1745 1BB1 PDB NFT CRYSTAL STRUCTURE OF A DESIGNED, THERMOSTABLE HETEROTRIMERIC COILED COIL >1bb1_A mol:protein length:36 DESIGNED, THERMOSTABLE HETEROTRIMERIC COILED COIL XAEIAAIEYEQAAIKEEIAAIKDKIAAIKEYIAAIX >1bb1_B mol:protein length:36 DESIGNED, THERMOSTABLE HETEROTRIMERIC COILED COIL XEKIAAIKEEQAAIEEEIQAIKEEIAAIKYLIAQIX >1bb1_C mol:protein length:36 DESIGNED, THERMOSTABLE HETEROTRIMERIC COILED COIL XAEIAAIKYKQAAIKNEIAAIKQEIAAIEQMIAAIX
1746 1BB3 PDB NFT HUMAN LYSOZYME MUTANT A96L >1bb3_A mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV >1bb3_B mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
1746 Q9LJB4 AF NFT Malonyl-CoA:anthocyanidin 5-O-glucoside-6''-O-malonyltransferase >sp|Q9LJB4|5MAT_ARATH Malonyl-CoA:anthocyanidin 5-O-glucoside-6''-O-malonyltransferase OS=Arabidopsis thaliana OX=3702 GN=5MAT PE=1 SV=1 MVNFNSAVNILEVVQVSPPSSNSLTLPLTYFDLGWLKLHPVDRVLFYHVPELTRSSLISKLKSSLSATLLHYLPLAGRLVWDSIKTKPSIVYSPDDKDAVYLTVAESNGDLSHLSGDEPRPATEFHSLVPELPVSDESARVLAVQVTFFPNQGFSLGVTAHHAVLDGKTTAMFLKAWAHNCKQEQEALPHDLVPSLDRIIVQDPTGLETKLLNRWISASNNKPSLKLFPSKIIGSDILRVTYRLTREDIKKLRERVETESHAKQLRLSTFVITYAYVITCMVKMRGGDPTRFVCVGFASDFRSRLNPPLPPTFFGNCIVGSGDFDVKAEPILEEGEGKGFITAVETLTGWVNGLCPENIEKNMLLPFEAFKRMEPGRQMISVAGSTRLGIYGSDFGWGKPVKVEIVTIDKDASVSLSESGDGSGGVEVGVCLKKDDVERFGSLFSIGLE
1746 HLA01843 C*05:08 HLA NFT C*05:08 >HLA:HLA01843 C*05:08 366 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADKAAQITQRKWEAAREAEQWRAYLEGTCVEWLRRYLENGKKTLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWGPSSQPTIPIVGIVAGLAVLAVLAVLGAVMAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1747 HLA01844 C*07:22 HLA NFT C*07:22 >HLA:HLA01844 C*07:22 366 bp MRVMAPRALLLLLSGGLALTETWACSHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQNYKRQAQADRVSLRNLRGYYNQSEDGSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKLEAARAAEQWRAYLEGTCVEWLRRYLENGKETLQRAEPPKTHVTHHPLSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHMQHEGLQEPLTLSWEPSSQPTIPIMGIVAGLAVLVVLAVLGAVVTAMMCRRKSSGGKGGSCSQAACSNSAQGSDESLITCKA
1747 Q9ZUJ5 AF NFT Metalloendoproteinase 5-MMP >sp|Q9ZUJ5|5MMP_ARATH Metalloendoproteinase 5-MMP OS=Arabidopsis thaliana OX=3702 GN=5MMP PE=1 SV=1 MRTLLLTILIFFFTVNPISAKFYTNVSSIPPLQFLNATQNAWETFSKLAGCHIGENINGLSKLKQYFRRFGYITTTGNCTDDFDDVLQSAINTYQKNFNLKVTGKLDSSTLRQIVKPRCGNPDLIDGVSEMNGGKILRTTEKYSFFPGKPRWPKRKRDLTYAFAPQNNLTDEVKRVFSRAFTRWAEVTPLNFTRSESILRADIVIGFFSGEHGDGEPFDGAMGTLAHASSPPTGMLHLDGDEDWLISNGEISRRILPVTTVVDLESVAVHEIGHLLGLGHSSVEDAIMFPAISGGDRKVELAKDDIEGIQHLYGGNPNGDGGGSKPSRESQSTGGDSVRRWRGWMISLSSIATCIFLISV
1747 1BB4 PDB NFT HUMAN LYSOZYME DOUBLE MUTANT A96L, W109H >1bb4_A mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAHVAWRNRCQNRDVRQYVQGCGV >1bb4_B mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAHVAWRNRCQNRDVRQYVQGCGV
1748 1BB5 PDB NFT HUMAN LYSOZYME MUTANT A96L COMPLEXED WITH CHITOTRIOSE >1bb5_A mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV >1bb5_B mol:protein length:130 LYSOZYME KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACLKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
1748 Q0CRQ4 AF NFT Adenylate-forming reductase >sp|Q0CRQ4|5MOAR_ASPTN Adenylate-forming reductase OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=ATEG_03630 PE=1 SV=1 MSPIAIDTAPFQRARVNLLHPEDPKAVKSIVQLLQFNAEHNPDHVFCLQLPSKQDDAIGNPIRITHLQFYRAVSYCTQRLQEEIDGLHGPRVNEDGTVTKCSPVVLFMESNVGLLIHLLALMSLGVPVAVLSARLSPTAVQHLMSSIRAQSVIASPRLKGTIEEAIASDNNTPAIGVRMYTQRPFEDDLENSRTLDLPATNEESHFISENDRNVLILHSSGTTGLPKPIYQPHRYLLNYSECHELGPDDALGTVLSALPLFHGFGLVAPCLAMTVGKPFMLPPSNTIPTGSLIIELIQSFQPTALMTVPHILEEITTLPPEQSISALQPLEFVLCGGGPLKISVAEALAASGVNLLAHFGTTETGPLGVVFVPTPDYDWHYWKLRQDINYRLDEVDANSADGNQYKLTVHPFGWDSAFEIQDILLSRGAEYKHHLRAVGRKDDLIVLANGEKLVPRVLETLLMQDERVKSAVAFGEGKFEIGVIVEPTHKVSDEEDFKAALWAIVLEAGAQMDSHAQVSSPSSIILATPEKPVPRSDKGSILRRETYRVYDEEISRVYEVLDRASEETTALNLQSDSLEEDLKDLIQREIGWKISPSEWLQDSDLFELGMNSLQAIRLHRLLLSSLPVDSRERVGADFVYRSPSVSKLGASLRHLAANENGHRNDPETEIDELICLNSFIARQDATVLLTGSTGNLGSNLLAHLTTLPRVKKVICLNRRGSDTSTAHTDLVERQLAIAKSKGVVIDPESASKIEVIPCDPSADFFGLPAEVYTHLTAQTTHILHNAWPMDFKRNVASFQSQFQYLNNLLRVAHDTRLCRPSIKPRFLFVSSIAVVGQYPRTHGTRLIPEVPSDKSSIIEDFGYGKAKYVCEEIMRAAADRYPEMQLGIVRVGQMSGSSRTGYWNPKEHFPTLIKFASMVGQLPAIKQTLSWIAVDNAATVLSDILFAPSLSGIYHLENPIRQAWQDVLDIFASSLYINTVNVPFDQWLRNVQAAVQELGTEDERMEYDLLAEFLEKDFQRMATGKVILDTSRSRAVSETLREVGEISEEVVWKYVREWRRAGTLRAPLE
1748 HLA01845 B*15:83:01:01 HLA NFT B*15:83:01:01 >HLA:HLA01845 B*15:83:01:01 362 bp MRVTAPRTVLLLLSGALALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQDRAYLEGTCVEWLRRYLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDVSLTA
1749 HLA01846 B*35:47 HLA NFT B*35:47 >HLA:HLA01846 B*35:47 362 bp MRVTAPRTVLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDATSPRKEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRADPPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDVSLTA
1749 Q0CRQ5 AF NFT 5-methylorsellinic acid synthase >sp|Q0CRQ5|5MOAS_ASPTN 5-methylorsellinic acid synthase OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=ATEG_03629 PE=1 SV=1 MTPTLLLCGSQAIQWSEDYLSSLREMLLADSALQPLVHAIRDLPQLWATLLEADTALHKMPGKQTLDRFTRWLDGERLLEKDSPSDLNMIMSPLTVIMQLVEYISHLHQSNLTHLQILDGAKHGGIQGFCTGFLAAITLSISRDESDVAELGTVALRLATCIGAYVDLDQCNSSGFACLAVRWPTAADERKVKDILETYNGAYLSVRSDVASATLTVPRAAKSSIIDELSNIGAHVKDIPLSGRFHNQVNRELFAKLAALCKSTIGLQFPGHCRPLVPLRSNADGELLSGNEALHVAALNSLLLHVSDWHKTVSKAMDSLSQTTAEPEVSVLGLGDCIPRTIRQSRALHVSHIKTGSTQSHDDPYQYPGDSIAIVGMGCRFPGADSLEEYWKVIESATSMLGDLPEGRFPKTNLRRDPNGKIPLNGNFLRHPDLWDHRFFKRSSREAASMDPQHRLALEVAYEALESAGYFAQRSPAKDIGCYMGVAASDYEDNVASHAPTAFSVLGMVRAFTSGKISHFFGLSGPSLVFDTACSSSLVAIHTACRALQANECSMALAGGVNVITSPTLHQNLGAANFLSPTGGSKSFDDRADGYCRGEGAGIVLLKRLDRAIAEKDRILGVIAGSAVNQNDNAYPVTVPVSMSQTALYRRVLDMSGLSPRPVSYVEAHGTGTPKGDPIECASIREVFGGQVNRKLYFGSVKANIGHAEAASGVAGLIKVLLMMQKRSIPPQALFASLNKSIPPLEPDNMAIAQRVTPWSEEFYAACVNNYGAAGSNAALIVTQPPNIRRGSHAGVALKNCPILLSANTAGSLRQTTVVLREFLAHNRAISENDLLKSTAFHLAKRFNPSFKYRHSFSVASLNQLDEKLQICSQLPDSEFLLPPNHRPVVLAFGGQTGNVVHLSEGVYRGSSILRKYLDKCDMQLRQLGLTSIFPTIFEQKSIEDTIQLHCTMFSLQYASAMAWIAAGLQVQTVIGHSFGQLTAMCVAGVLSLVDAIRLIAGRATIIQEKWGAERGCMLLVQGELALVQKLISQAREATSHVVEIACFNGPNSFVLVGSEADIDAFDGLAASSLKTRKMAVTHGFHSRFVDTIMDDYQKLADSLEYKSPTIAIETCSSGETWDMFTADKVAKQSRQPVYFAEAVERIAQRLGSCTWIEAGSGSGITSMARRALNDTTNHDFHAVNLGGPEPWAAFADTTVSLWQAGVQVDYWPFHKEQQLEYLPLNLPPYQFERSRHWLAYVDRPGADGLIQSKETQSVETKPKLVSFVKYLDSNRQTAEFSIGQDCEQYQALVRGHAVLANTLCPAALYVEMAAYAASLLVPDFSPSTYTSRVEDLHMQSPLAIDLKRGLRLVLSSSGSGTWQFIMQSFSLSDSDNATQHASGTVNISSLTSEKLQSRFSRYKRIVNYERCESLLSDSGTSAIQGSLVYKMFDKVVVYSDIFRGVSKIASRGHEVTGQVSLPSAGLELVKDSVCNPLVVDNFTQVAGLHVNSLDDCGSNEVYLCNGIEQIDACKPLDASGSWLVHSSFDRVGTRELVNDIFVFDASTKELVMTLFGLRFAKVPTASLKRALERANTVQNPVQTPSLKVTEPSANVPKAQPVSTYPKPMKPAPAADAQIRTATMALLNEVADVPLSDIADGAQLEDLGIDSLMAAELLSAIRERFNLDIPTSTFASIVDFKGLYQHIASGTDAGILTPSSSGMESDDSILEVQYTDTSTPFSEIAYPLEDKDAGDSAQAGQIAQLSQLFAEHLECPLPIPSGETLRDIGLDSLVGMELAADIQQAFGRKVDLATLDPECTFGQFCDMVIPKPTLSVPTVSEKVDKTVRWASTEIAYTAKRENKMQDPVEMQSDGGNVNYLAHCAEDFAQIRKNYTTFAKQTGFADFRANVYPQQKELVCAYVTEAFAALGSDLKTIPSGSPLPPIQHIARHAKVMKQYYKVLEDSGLITITDNGPIRTAKPVSPVKSEDLYQMIYSAFPQHRGEHKLLNSTGSKLASCLKGETDPLQILFGSKASKDLMEDVYTNSPMFATGTRILGDFFVKTFSKYKGPEKLRILELGAGTGGTTKYIVEKLLEHNIPFTYTFTDLSPSLVALAKRKFSHYGCLEFLVLDIEKTPPEHLTNSYHAILSSNCVHATKNLLNSTTNTRKLLRADGFLCLLELTRNLFWLDCVFGLLEGWWLFEDGRKHVLADEYLWKETLLEAGFRHVDWSDDDTEESDQFRVITGFVADIGHNALDQAKPVTTKLPTMETTSFATVDGIPLLADIYYPTKPDAPGVKRPIALMIHGGGHIMLSRRDIRPKQTRLLLERGLLPVSIEYRLCPEVSLTEGPIPDACAALNWVRTVLPTLRLQRPDIHPNGDKVAVVGWSTGGTLSMMLAFSAPQRGIRPPDAILAFYCPTDYEAEFFRTPNYPEDTSEVVPEIYDILEGVQERPITAYNVPAHQGATGGWMSLSDPRSRIALHMNWRGQMMPVLLDGLPSKKTLLEAGGDASPSKWMDLPQPSVDRLRAVSPYAQIVQGNYRVPTFLVHGTRDDLIPWEQSVRTKDALTSQGVAAGVAVVDDAVHLFDLYRDPEGRYWNAVLEGYEFLLRHL
1749 1BB6 PDB NFT LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOTRIOSE >1bb6_A mol:protein length:129 LYSOZYME KVYDRCELARALKASGMDGYAGNSLPNWVCLSKWESSYNTQATNRNTDGSTDYGIFQINSRYWCDDGRTPGAKNVCGIRCSQLLTDDLTVAIRCAKRVVLDPNGIGAWVAWRLHCQNQDLRSYVAGCGV
1750 1BB7 PDB NFT LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOBIOSE >1bb7_A mol:protein length:129 LYSOZYME KVYDRCELARALKASGMDGYAGNSLPNWVCLSKWESSYNTQATNRNTDGSTDYGIFQINSRYWCDDGRTPGAKNVCGIRCSQLLTDDLTVAIRCAKRVVLDPNGIGAWVAWRLHCQNQDLRSYVAGCGV
1750 Q5ZL42 AF NFT eIF5-mimic protein 1 >sp|Q5ZL42|5MP1_CHICK eIF5-mimic protein 1 OS=Gallus gallus OX=9031 GN=BZW2 PE=2 SV=1 MNKNQKPVLTGQRFKTRKRDEKEKFEPTVFRDTIVQGLNEAGSDLEAIAKFLDSAGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDNDKTKMTRHCVFFAEEDHDAIRNYAQVFNKLIRRYKYLEKAFEDEIKKLLLFLKAFSETEQTKLAMLSGILLANGTLPATILTSLFTDNIVKEGIAASFAVKLFKAWMAEKDANSVTSALRKANLDKRLLELFPANRQNVDHFAKYFTEAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEMVLYVKEEMKRNELPEPAVIGLLWTCVMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSTQGQSELILLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHVAKGKSVFLDQMKKFVEWLQNAEEEFRI
1750 HLA01847 A*23:12 HLA NFT A*23:12 >HLA:HLA01847 A*23:12 365 bp MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDEETGKVKAHSQTHRENLRIALRYYNQSEAGSHTLQMMFGCDVGSDGRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVDGLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQPTVHIVGIIAGLVLLGAVITGAVVAAVMWRRNSSDRKGGSYSQAASSDSAQGSDVSLTACKV
1751 HLA01848 DRB1*11:49:01 HLA NFT DRB1*11:49:01 >HLA:HLA01848 DRB1*11:49:01 89 bp RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYARFDSDVGEFRAVTELGRPDEEYWNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRR
1751 Q1LUC1 AF NFT eIF5-mimic protein 1 >sp|Q1LUC1|5MP1_DANRE eIF5-mimic protein 1 OS=Danio rerio OX=7955 GN=bzw2 PE=2 SV=1 MNTGKQQKPVLTGQRFKTRKRDEKEKFEPTVFRDTIVQGLNEAGGDLDALAKFLDVTGSRLDYRRYADTLFDILIAGSMLAPGGTRIDDADKTKVTQHCVFNAEENHTTIRSYAQVFNKLIRRYKYLEKAFEEEIKKLLLFLKGFTESEQTKLAMLTGVLLANGTLPPPILTSLFSDNLVKEGISASFAVKMFKAWIAEKDANAVTSALRKANLDKKLLELFPANKQNVEHFTKFFTEAGLKELSDFLRTQQTLGTRKELQKELQERLSQQCPIREIVVYVKEEMKKNDLQEQAVIGLLWTCLMNAVEWNKKEELVTEQALKHLKHYAPLLAVFSTQGQSELVLLLKIQEYCYDNIHFMKSFSKIVVLFYKADVVSEEAIMKWYKDAHAAKGKSVFLEQMKKFVEWLQNAEEESESEGEED
1751 1BB8 PDB NFT N-TERMINAL DNA BINDING DOMAIN FROM TN916 INTEGRASE, NMR, 25 STRUCTURES >1bb8_A mol:protein length:71 INTEGRASE EKRRDNRGRILKTGESQRKDGRYLYKYIDSFGEPQFVYSWKLVATDRVPAGKRDCISLREKIAELQKDIHD
1752 1BB9 PDB NFT CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM RAT AMPHIPHYSIN 2 >1bb9_A mol:protein length:115 AMPHIPHYSIN 2 MGSSHHHHHHSSGLVPRGSHMATVNGAVEGSTTTGRLDLPPGFMFKVQAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFPENFTERVQ
1752 Q9Y6E2 AF NFT eIF5-mimic protein 1 >sp|Q9Y6E2|5MP1_HUMAN eIF5-mimic protein 1 OS=Homo sapiens OX=9606 GN=BZW2 PE=1 SV=1 MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSETEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCIMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELILLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHVAKGKSVFLDQMKKFVEWLQNAEEESESEGEEN
1752 HLA01849 DRB1*09:03 HLA NFT DRB1*09:03 >HLA:HLA01849 DRB1*09:03 89 bp RFLKQDKFECHFFNGTERVRYLHRGIYNQEENVRFDSDVGEYRAVTELGRPVAESWNSQKDFLEDRRAEVDTVCRHNYGVGESFTVQRR
1753 HLA01850 B*35:48 HLA NFT B*35:48 >HLA:HLA01850 B*35:48 362 bp MRVTAPRTVLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMSGCDLGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRADPPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDVSLTA
1753 Q4R6R4 AF NFT eIF5-mimic protein 1 >sp|Q4R6R4|5MP1_MACFA eIF5-mimic protein 1 OS=Macaca fascicularis OX=9541 GN=BZW2 PE=2 SV=1 MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSETEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCIMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELILLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHVAKGKSVFLDQMKKFVEWLQNAEEESESEGEGN
1753 1BBA PDB NFT SEQUENCE-SPECIFIC 1H NMR ASSIGNMENTS AND SOLUTION STRUCTURE OF BOVINE PANCREATIC POLYPEPTIDE >1bba_A mol:protein length:36 BOVINE PANCREATIC POLYPEPTIDE APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY
1754 1BBB PDB NFT A THIRD QUATERNARY STRUCTURE OF HUMAN HEMOGLOBIN A AT 1.7-ANGSTROMS RESOLUTION >1bbb_A mol:protein length:141 HEMOGLOBIN A (CARBONMONOXY) (ALPHA CHAIN) VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR >1bbb_C mol:protein length:141 HEMOGLOBIN A (CARBONMONOXY) (ALPHA CHAIN) VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR >1bbb_B mol:protein length:146 HEMOGLOBIN A (CARBONMONOXY) (BETA CHAIN) VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH >1bbb_D mol:protein length:146 HEMOGLOBIN A (CARBONMONOXY) (BETA CHAIN) VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH
1754 Q91VK1 AF NFT eIF5-mimic protein 1 >sp|Q91VK1|5MP1_MOUSE eIF5-mimic protein 1 OS=Mus musculus OX=10090 GN=Bzw2 PE=1 SV=1 MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSEAEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCIMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELVLLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHAAKGKSVFLDQMKKFVEWLQNAEEESESEGEES
1754 HLA01851 C*04:13:01:01 HLA NFT C*04:13:01:01 >HLA:HLA01851 C*04:13:01:01 366 bp MRVMAPRTLILLLSGALALTETWAGSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWKPSSQPTIPIVGIVAGLAVLAVLAVLGAMVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1755 HLA01852 A*29:11 HLA NFT A*29:11 >HLA:HLA01852 A*29:11 365 bp MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDLQTRNVKAQSQTDRANLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAPITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQRYTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYSQAASSDSAQGSDMSLTACKV
1755 Q2L4X1 AF NFT eIF5-mimic protein 1 >sp|Q2L4X1|5MP1_MUSMM eIF5-mimic protein 1 OS=Mus musculus molossinus OX=57486 GN=Bzw2 PE=2 SV=1 MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSEAEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCIMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELVLLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHAAKGKSVFLDQMKKFVEWLQNAEEESESEGEES
1755 1BBC PDB NFT STRUCTURE OF RECOMBINANT HUMAN RHEUMATOID ARTHRITIC SYNOVIAL FLUID PHOSPHOLIPASE A2 AT 2.2 ANGSTROMS RESOLUTION >1bbc_A mol:protein length:124 PHOSPHOLIPASE A2 NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC
1756 1BBD PDB NFT THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2 >1bbd_L mol:protein length:220 IGG2A-KAPPA 8F5 FAB (LIGHT CHAIN) DIVMTQSPSSLTVTTGEKVTMTCKSSQSLLNSRTQKNYLTWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLSISGVQAEDLAVYYCQNNYNYPLTFGAGTKLELKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNEC >1bbd_H mol:protein length:218 IGG2A-KAPPA 8F5 FAB (HEAVY CHAIN) EVQLQQSGAELVRPGASVKLSCTTSGFNIKDIYIHWVKQRPEQGLEWIGRLDPANGYTKYDPKFQGKATITVDTSSNTAYLHLSSLTSEDTAVYYCDGYYSYYDMDYWGPGTSVTVSSAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPR
1756 Q9WTT7 AF NFT eIF5-mimic protein 1 >sp|Q9WTT7|5MP1_RAT eIF5-mimic protein 1 OS=Rattus norvegicus OX=10116 GN=Bzw2 PE=1 SV=1 MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSEAEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCVMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELVLLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHAAKGKSVFLDQMKKFVEWLQNAEEESESEGEES
1756 HLA01853 C*04:14 HLA NFT C*04:14 >HLA:HLA01853 C*04:14 366 bp MRVMAPRTLILLLSGALALTETWAGSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQQRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWKPSSQPTIPIVGIVAGLAVLAVLAVLGAMVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1757 HLA01854 DRB1*13:63 HLA NFT DRB1*13:63 >HLA:HLA01854 DRB1*13:63 89 bp RFLEYSTSECHFFNGTERVRFLDRYFHNQEENVRFDSDVGEFRAVTELGRPDAEYWNSQKDFLEDERAAVDTYCRHNYGVGESFTVQRR
1757 Q6PD83 AF NFT eIF5-mimic protein 2-A >sp|Q6PD83|5MP2A_DANRE eIF5-mimic protein 2-A OS=Danio rerio OX=7955 GN=bzw1a PE=2 SV=1 MNNQKQQKPTLTGQRFKTRKRDEKERFDPSQFQESIVQGLNQTGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLSDDLTRTEYCLFTASEDLETMQAYAQVFNKLIRRYKYLEKGFEEEIKKLLLFLKGFTESERNKLAMLTGILLANGNISASILNSLFNENLVKEGVSAAFAVKLFKSWINEKDINSVAASLRKVGMDNRLMELFPANKRSCEHFSKYFTDAGLKELSDFARNQQSIGARKELQKELQEQMSRGETLKDIIAYVREEMKKTSISEQTMIGIVWTSVMSSVEWNKKEELVTEQAIKHLKQYSPLLKAFTSQGLSELTLLLKIQEYCYDNIHFMKAFQKIVVLLYKADVLSEEVILKWYTEGHVAKGKSVFLEQMKKFVEWLKNAEEESESEEEEGD
1757 1BBG PDB NFT RAGWEED POLLEN ALLERGEN FROM AMBROSIA TRIFIDA V, NMR, MINIMIZED AVERAGE STRUCTURE >1bbg_A mol:protein length:40 POLLEN ALLERGEN 5 DDGLCYEGTNCGKVGKYCCSPIGKYCVCYDSKAICNKNCT
1758 1BBH PDB NFT ATOMIC STRUCTURE OF A CYTOCHROME C' WITH AN UNUSUAL LIGAND-CONTROLLED DIMER DISSOCIATION AT 1.8 ANGSTROMS RESOLUTION >1bbh_A mol:protein length:131 CYTOCHROME C' AGLSPEEQIETRQAGYEFMGWNMGKIKANLEGEYNAAQVEAAANVIAAIANSGMGALYGPGTDKNVGDVKTRVKPEFFQNMEDVGKIAREFVGAANTLAEVAATGEAEAVKTAFGDVGAACKSCHEKYRAK >1bbh_B mol:protein length:131 CYTOCHROME C' AGLSPEEQIETRQAGYEFMGWNMGKIKANLEGEYNAAQVEAAANVIAAIANSGMGALYGPGTDKNVGDVKTRVKPEFFQNMEDVGKIAREFVGAANTLAEVAATGEAEAVKTAFGDVGAACKSCHEKYRAK
1758 Q803N9 AF NFT eIF5-mimic protein 2-B >sp|Q803N9|5MP2B_DANRE eIF5-mimic protein 2-B OS=Danio rerio OX=7955 GN=bzw1b PE=2 SV=2 MSYQKQQKPTLTGQRFKTRKRDEKERFDPSQFQESIVQGLNQTGTDLEAVAKFLDSSGAKLDYRRYAETLFDILVAGGMLAPGGALSDDMTRTKYCVFTAQEDIKTMKAYAQVFNKLIRRYKYLEKGFEEEIKKLLLFLKGFSESERNKLAMLTGVLLGNGSLSAAILSSLFNDNLVKEGVSPAFAVKLFKSWISEKDINSVAGSLRKVSMDNRLMELFPVNKRSYEHFSRYFTGAGLKEISDFARNQQSLGARKELQKELQEQISLGVSFKEIIDYCKEEMKRSSISEQLMIGIMWTSLMSDMEWNKKEELVTEQAIKHLKQHSPLLKAFSTQAQSELSLLQRIQEFCYDNIHFMKTFQKMVLLLYKVDVLSEEAVLKWFTEAHLAKGKSVFLEQMKTFVEWLKNAEEESESEEESD
1758 HLA01855 C*03:03:04 HLA NFT C*03:03:04 >HLA:HLA01855 C*03:03:04 366 bp MRVMAPRTLILLLSGALALTETWAGSHSMRYFYTAVSRPGRGEPHFIAVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEARSHIIQRMYGCDVGPDGRLLRGYDQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLKNGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWEPSSQPTIPIVGIVAGLAVLAVLAVLGAVVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1759 HLA01856 C*05:09:01 HLA NFT C*05:09:01 >HLA:HLA01856 C*05:09:01 366 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADKAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWGPSSQPTIPIVGIVAGLAVLAVLAVLGAVMAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1759 Q5ZLT7 AF NFT eIF5-mimic protein 2 >sp|Q5ZLT7|5MP2_CHICK eIF5-mimic protein 2 OS=Gallus gallus OX=9031 GN=BZW1 PE=2 SV=1 MNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLTETGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADDMTRTDVCVFAAQEDLETMQAFAQVFNKLIRRYKYLEKGFEDEVKKLLLFLKGFSESERNKLAMLTGILLANGTLNASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAVSLRKVNMDNRLMELFPANKQSVEHFSKYFTEAGLKELSEYVRNQQTIGARKELQKELQEQMSRGDPFKDIILYVKEEMKKNNISEQTVIAIIWSSVMSTVEWNKKEELVAEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKAFQKIVVLFYKAEVLSEEPILKWYKDAHLAKGKSVFLEQMKKFVEWLKNAEEESESEAEEGD
1759 1BBI PDB NFT THREE-DIMENSIONAL STRUCTURE OF SOYBEAN TRYPSIN(SLASH)CHYMOTRYPSIN BOWMAN-BIRK INHIBITOR IN SOLUTION >1bbi_A mol:protein length:71 TRYPSIN/CHYMOTRYPSIN BOWMAN-BIRK INHIBITOR DDESSKPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKPSEDDKEN
1760 1BBJ PDB NFT CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS >1bbj_L mol:protein length:211 IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYAATNLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTRLEIKRADAAPTVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR >1bbj_A mol:protein length:211 IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYAATNLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTRLEIKRADAAPTVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR >1bbj_H mol:protein length:212 IGG4-KAPPA B72.3 FAB (HEAVY CHAIN) QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWAKQKPEQGLEWIGYISPGNDDIKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKRSYYGHWGQGTTLTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRV >1bbj_B mol:protein length:212 IGG4-KAPPA B72.3 FAB (HEAVY CHAIN) QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWAKQKPEQGLEWIGYISPGNDDIKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKRSYYGHWGQGTTLTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRV
1760 Q7L1Q6 AF NFT eIF5-mimic protein 2 >sp|Q7L1Q6|5MP2_HUMAN eIF5-mimic protein 2 OS=Homo sapiens OX=9606 GN=BZW1 PE=1 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLTETGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADDMMRTDVCVFAAQEDLETMQAFAQVFNKLIRRYKYLEKGFEDEVKKLLLFLKGFSESERNKLAMLTGVLLANGTLNASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAASLRKVSMDNRLMELFPANKQSVEHFTKYFTEAGLKELSEYVRNQQTIGARKELQKELQEQMSRGDPFKDIILYVKEEMKKNNIPEPVVIGIVWSSVMSTVEWNKKEELVAEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKAFQKIVVLFYKAEVLSEEPILKWYKDAHVAKGKSVFLEQMKKFVEWLKNAEEESESEAEEGD
1760 HLA01857 C*08:11 HLA NFT C*08:11 >HLA:HLA01857 C*08:11 366 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARTAEQLRAYLEGTCVEWLRRYLENGKKTLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWGPSSQPTIPIVGIVAGLAVLAVLAVLGAVMAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA
1761 HLA01858 B*13:13:01 HLA NFT B*13:13:01 >HLA:HLA01858 B*13:13:01 298 bp MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFITVGYVDDTQFVRFDSDATSPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQLKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW
1761 Q9CQC6 AF NFT eIF5-mimic protein 2 >sp|Q9CQC6|5MP2_MOUSE eIF5-mimic protein 2 OS=Mus musculus OX=10090 GN=Bzw1 PE=1 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLTETGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADDMMRTDVCVFAAQEDLETMQAFAQVFNKLIRRYKYLEKGFEDEVKKLLLFLKGFSESERNKLAMLTGVLLANGTLNASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAASLRKVSMDNRLMELFPANKQSVEHFTKYFTEAGLKELSEYVRNQQTIGARKELQKELQEQMSRGDPFKDIILYVKEEMKKNNIPEPVVIGIVWSSVMSTVEWNKKEELVAEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKAFQKIVVLFYKAEVLSEEPILKWYKDAHVAKGKSVFLEQMKKFVEWLKNAEEESESEAEEGD
1761 1BBL PDB NFT THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE E3-BINDING DOMAIN OF THE DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE CORE FROM THE 2-OXOGLUTARATE DEHYDROGENASE MULTIENZYME COMPLEX OF ESCHERICHIA COLI >1bbl_A mol:protein length:51 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE YASLEEQNNDALSPAIRRLLAEHNLDASAIKGTGVGGRLTREDVEKHLAKA
1762 1BBN PDB NFT THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 BY MULTI-DIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY >1bbn_A mol:protein length:133 INTERLEUKIN-4 EAEAHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKDTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEADQSTLENFLERLKTIMREKYSKCSS
1762 Q5R7L4 AF NFT eIF5-mimic protein 2 >sp|Q5R7L4|5MP2_PONAB eIF5-mimic protein 2 OS=Pongo abelii OX=9601 GN=BZW1 PE=2 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLTETGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADDMMRTDVCVFAAQEDLETMQAFAQVFNKLIRRYKYLEKGFEDGVKKLLLFLKGFSESERNKLAMLTGVLLANGTLNASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAASLRKVSMDNRLMELFPANKQSVEHFTKYFTEAGLKELSEYVRNQQTIGARKELQKELQEQMSRGDPFKDIILYVKEEMKKNNIPEPVVIGIVWSSVMSTVEWNKKEELVAEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKAFQKIVVLFYKAEVLSEGPILKWYKDAHVAKGKSVFLEQMKKFVEWLKNAEEESESEAEEGD
1762 HLA01859 C*04:15:01 HLA NFT C*04:15:01 >HLA:HLA01859 C*04:15:01 181 bp SHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMYGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQRA
1763 HLA01860 DRB1*08:28 HLA NFT DRB1*08:28 >HLA:HLA01860 DRB1*08:28 89 bp RFLEYSTGECYFFNGTERVRFLDRYFYNQEEYVRFDSDVGEFRAVTELGRPDAEYWNSQKDFLEDRRALVDTYCRHNYGVVESFTVQRR
1763 Q6P7P5 AF NFT eIF5-mimic protein 2 >sp|Q6P7P5|5MP2_RAT eIF5-mimic protein 2 OS=Rattus norvegicus OX=10116 GN=Bzw1 PE=1 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLTETGTDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADDMMRTDVCVFAAQEDLETMQAFAQVFNKLIRRYKYLEKGFEDEVKKLLLFLKGFSESERNKLAMLTGVLLANGTLNASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAASLRKVSMDNRLMELFPANKQSVEHFTKYFTEAGLKELSEYVRNQQTIGARKELQKELQEQMSRGDPFKDIILYVKEEMKKNNIPEPVVIGIVWSSVMSTVEWNKKEELVAEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKAFQKIVVLFYKAEVLSEEPILKWYKDAHVAKGKSVFLEQMKKFVEWLKNAEEESESEAEEGD
1763 1BBO PDB NFT HIGH-RESOLUTION SOLUTION STRUCTURE OF THE DOUBLE CYS2*HIS2 ZINC FINGER FROM THE HUMAN ENHANCER BINDING PROTEIN MBP-1 >1bbo_A mol:protein length:57 HUMAN ENHANCER-BINDING PROTEIN MBP-1 KYICEECGIRAKKPSMLKKHIRTHTDVRPYHCTYCNFSFKTKGNLTKHMKSKAHSKK
1764 1BBP PDB NFT MOLECULAR STRUCTURE OF THE BILIN BINDING PROTEIN (BBP) FROM PIERIS BRASSICAE AFTER REFINEMENT AT 2.0 ANGSTROMS RESOLUTION. >1bbp_A mol:protein length:173 BILIN BINDING PROTEIN NVYHDGACPEVKPVDNFDWSNYHGKWWEVAKYPNSVEKYGKCGWAEYTPEGKSVKVSNYHVIHGKEYFIEGTAYPVGDSKIGKIYHKLTYGGVTKENVFNVLSTDNKNYIIGYYCKYDEDKKGHQDFVWVLSRSKVLTGEAKTAVENYLIGSPVVDSQKLVYSDFSEAACKVN >1bbp_B mol:protein length:173 BILIN BINDING PROTEIN NVYHDGACPEVKPVDNFDWSNYHGKWWEVAKYPNSVEKYGKCGWAEYTPEGKSVKVSNYHVIHGKEYFIEGTAYPVGDSKIGKIYHKLTYGGVTKENVFNVLSTDNKNYIIGYYCKYDEDKKGHQDFVWVLSRSKVLTGEAKTAVENYLIGSPVVDSQKLVYSDFSEAACKVN >1bbp_C mol:protein length:173 BILIN BINDING PROTEIN NVYHDGACPEVKPVDNFDWSNYHGKWWEVAKYPNSVEKYGKCGWAEYTPEGKSVKVSNYHVIHGKEYFIEGTAYPVGDSKIGKIYHKLTYGGVTKENVFNVLSTDNKNYIIGYYCKYDEDKKGHQDFVWVLSRSKVLTGEAKTAVENYLIGSPVVDSQKLVYSDFSEAACKVN >1bbp_D mol:protein length:173 BILIN BINDING PROTEIN NVYHDGACPEVKPVDNFDWSNYHGKWWEVAKYPNSVEKYGKCGWAEYTPEGKSVKVSNYHVIHGKEYFIEGTAYPVGDSKIGKIYHKLTYGGVTKENVFNVLSTDNKNYIIGYYCKYDEDKKGHQDFVWVLSRSKVLTGEAKTAVENYLIGSPVVDSQKLVYSDFSEAACKVN
1764 Q8AVM7 AF NFT eIF5-mimic protein 2 >sp|Q8AVM7|5MP2_XENLA eIF5-mimic protein 2 OS=Xenopus laevis OX=8355 GN=bzw1 PE=2 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLNETGNDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADEVIRTDVCVFSAQEDLETMQAFAQVFNKLIRRYKYLEKGFEEEVKKLLLFLKGFSESERNKLAMLTGILLANGNLSASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAGSLRKVNMDNRLMELFPANKQTVEHFTKYYTDAGLKELAEYVRNQQTIGARKEIHKELQEMISRGEAHKEISVYVKDEMKKNNISEQTVIGILWSSIMSCVEWNKKEELVTEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKSFQKIVVLFYKAEVLSEEPILKWYKDAHVAKGKSVFLEQMKKFVEWLKNAEEESESETEEGD
1764 HLA01861 DQA1*06:02 HLA NFT DQA1*06:02 >HLA:HLA01861 DQA1*06:02 175 bp DHVASYGVNLYQSYGPSGQFTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVTKHNLNILIKRSNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSETRFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHW
1765 HLA01862 C*02:09 HLA NFT C*02:09 >HLA:HLA01862 C*02:09 181 bp SHSMRYFYTAVSRPSRGEPHFIAVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQWRAYLEGECVEWLRRYLENGKETLQCA
1765 Q6P2Z0 AF NFT eIF5-mimic protein 2 >sp|Q6P2Z0|5MP2_XENTR eIF5-mimic protein 2 OS=Xenopus tropicalis OX=8364 GN=bzw1 PE=2 SV=1 MNNQKQQKPTLSGQRFKTRKRDEKERFDPTQFQDCIIQGLNETGNDLEAVAKFLDASGAKLDYRRYAETLFDILVAGGMLAPGGTLADEVIRTDVCVFSAQEDLETMQAFAQVFNKLIRRYKYLEKGFEEEVKKLLLFLKGFSESERNKLAMLTGILLANGNLSASILNSLYNENLVKEGVSAAFAVKLFKSWINEKDINAVAGSLRKVNMDNRLMELFPANKQTVEHFTKYFTDAGLKELAEYVRNQQTIGARKELQKELQEMMSRGEPLKEISMYVKDEMKKNNISEQTVIGILWSSVMSCVEWNKKEELVTEQAIKHLKQYSPLLAAFTTQGQSELTLLLKIQEYCYDNIHFMKSFQKIVVLFYKAEVLSEEPILKWYKDAHLAKGKSVFLEQMKKFVEWLKNAEEESESETEEGD
1765 1BBR PDB NFT THE STRUCTURE OF RESIDUES 7-16 OF THE A ALPHA CHAIN OF HUMAN FIBRINOGEN BOUND TO BOVINE THROMBIN AT 2.3 ANGSTROMS RESOLUTION >1bbr_L mol:protein length:49 EPSILON-THROMBIN TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR >1bbr_J mol:protein length:49 EPSILON-THROMBIN TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR >1bbr_M mol:protein length:49 EPSILON-THROMBIN TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR >1bbr_H mol:protein length:150 EPSILON-THROMBIN IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTT >1bbr_E mol:protein length:109 EPSILON-THROMBIN SVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS >1bbr_F mol:protein length:11 FIBRINOGEN ALPHA/ALPHA-E CHAIN PRECURSOR XDFLAEGGGVR >1bbr_G mol:protein length:11 FIBRINOGEN ALPHA/ALPHA-E CHAIN PRECURSOR XDFLAEGGGVR >1bbr_I mol:protein length:11 FIBRINOGEN ALPHA/ALPHA-E CHAIN PRECURSOR XDFLAEGGGVR >1bbr_K mol:protein length:259 EPSILON-THROMBIN IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS >1bbr_N mol:protein length:259 EPSILON-THROMBIN IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS
1766 1BBS PDB NFT X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN AND MOUSE RENINS >1bbs_A mol:protein length:340 RENIN LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR >1bbs_B mol:protein length:340 RENIN LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR
1766 Q7ZWS2 AF NFT 7-methylguanosine phosphate-specific 5'-nucleotidase A >sp|Q7ZWS2|5N3BA_XENLA 7-methylguanosine phosphate-specific 5'-nucleotidase A OS=Xenopus laevis OX=8355 GN=Nt5c3b-a PE=2 SV=2 MRLPVLGKDTVRMRDPEGLQDKITRIQRGGQEKLQIISDFDMTLSRFSRNGERCPTCYNIIDNSNIISDEGRKKLKCLFDIYYPLEIDPKKSIEEKYPLMVEWWSKAHDLFYEQRIQKDRLAQVVKESQATLRDGYDLFFNSLYQREIPLFIFSAGIGDVLEEIIRQAGVFHPNTKVVSNYMDFDDNGILTGFKGDLIHTYNKNSSVLKDTEYFKEISHRTNILLLGDTLGDLTMADGVSTVENIIKIGFLNDKVEELTEQFLQSYDIVLLRDETLDVVNGILQFVTAKN
1766 HLA01863 C*07:23 HLA NFT C*07:23 >HLA:HLA01863 C*07:23 181 bp SHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQADRVSLRNLRGYYNQSEDGSHTLQRMSGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITHRKLEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRA
1767 HLA01864 C*07:24 HLA NFT C*07:24 >HLA:HLA01864 C*07:24 366 bp MRVMAPRALLLLLSGGLALTETWACSHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQNYKRQAQADRVSLRNLRGYYNQSEDGSHTLQRMYGCDLGSDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKLEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRAEPPKTHVTHHPLSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHMQHEGLQEPLTLSWEPSSQPTIPIMGIVAGLAVLVVLAVLGAVVTAMMCRRKSSGGKGGSCSQAACSNSAQGSDESLITCKA
1767 Q2TAG6 AF NFT 7-methylguanosine phosphate-specific 5'-nucleotidase B >sp|Q2TAG6|5N3BB_XENLA 7-methylguanosine phosphate-specific 5'-nucleotidase B OS=Xenopus laevis OX=8355 GN=Nt5c3b-b PE=2 SV=1 MRLPVLGKDTVRMRDPEGLQDKITRIQRGGQEKLQIISDFDMTLSRFSRNGERCPTCYNIIDNSNIISDEGRKKLKCLFDIYYPLEIDPKKSIEEKYPLMVEWWSKAHDLFYEQRIQKDRLAQVVKEPQATLRDGYDLFFNNLYQREIPLFIFSAGIGDVLEEIIRQAGVFHPNTKVVSNYMDFDDNGILTGFKGDLIHTYNKNSSVLKDTEYFKEISHRTNILLLGDTLGDLTMADGVSTVENIIKIGFLNDKVEELTEQFLQSYDIVLLRDETLDVVNGILQFVTAKN
769729